Literature DB >> 33679718

Different Functions of Recombinantly Expressed Domains of Tenascin-C in Glial Scar Formation.

Dunja Bijelić1, Marija Adžić1, Mina Perić1, Igor Jakovčevski2, Eckart Förster2, Melitta Schachner3, Pavle R Andjus1.   

Abstract

Extracellular matrix glycoprotein tenascin-C (TnC) is highly expressed in vertebrates during embryonic development and thereafter transiently in tissue niches undergoing extensive remodeling during regeneration after injury. TnC's different functions can be attributed to its multimodular structure represented by distinct domains and alternatively spliced isoforms. Upon central nervous system injury, TnC is upregulated and secreted into the extracellular matrix mainly by astrocytes. The goal of the present study was to elucidate the role of different TnC domains in events that take place after spinal cord injury (SCI). Astrocyte cultures prepared from TnC-deficient (TnC-/-) and wild-type (TnC+/+) mice were scratched and treated with different recombinantly generated TnC fragments. Gap closure, cell proliferation and expression of GFAP and cytokines were determined in these cultures. Gap closure in vitro was found to be delayed by TnC fragments, an effect mainly mediated by decreasing proliferation of astrocytes. The most potent effects were observed with fragments FnD, FnA and their combination. TnC-/- astrocyte cultures exhibited higher GFAP protein and mRNA expression levels, regardless of the type of fragment used for treatment. Application of TnC fragments induced also pro-inflammatory cytokine production by astrocytes in vitro. In vivo, however, the addition of FnD or Fn(D+A) led to a difference between the two genotypes, with higher levels of GFAP expression in TnC+/+ mice. FnD treatment of injured TnC-/- mice increased the density of activated microglia/macrophages in the injury region, while overall cell proliferation in the injury site was not affected. We suggest that altogether these results may explain how the reaction of astrocytes is delayed while their localization is restricted to the border of the injury site to allow microglia/macrophages to form a lesion core during the first stages of glial scar formation, as mediated by TnC and, in particular, the alternatively spliced FnD domain.
Copyright © 2021 Bijelić, Adžić, Perić, Jakovčevski, Förster, Schachner and Andjus.

Entities:  

Keywords:  astrocyte; glial scar; microglia/macrophages; spinal cord injury; tenascin-C

Year:  2021        PMID: 33679718      PMCID: PMC7934619          DOI: 10.3389/fimmu.2020.624612

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  50 in total

1.  Inhibition of formation of a glial barrier as a means of permitting a peripheral nerve to grow into the brain.

Authors:  W F WINDLE; C D CLEMENTE; W W CHAMBERS
Journal:  J Comp Neurol       Date:  1952-04       Impact factor: 3.215

Review 2.  Expression and functional roles of neural cell surface molecules and extracellular matrix components during development and regeneration of peripheral nerves.

Authors:  R Martini
Journal:  J Neurocytol       Date:  1994-01

3.  Binding of contactin/F11 to the fibronectin type III domains 5 and 6 of tenascin is inhibited by heparin.

Authors:  P Weber; P Ferber; R Fischer; K H Winterhalter; L Vaughan
Journal:  FEBS Lett       Date:  1996-07-08       Impact factor: 4.124

4.  Differential expression of tenascin after denervation, damage or paralysis of mouse soleus muscle.

Authors:  A Irintchev; T F Salvini; A Faissner; A Wernig
Journal:  J Neurocytol       Date:  1993-11

5.  Expression of tenascin in the developing and adult cerebellar cortex.

Authors:  S Bartsch; U Bartsch; U Dörries; A Faissner; A Weller; P Ekblom; M Schachner
Journal:  J Neurosci       Date:  1992-03       Impact factor: 6.167

6.  Tenascin-C may accelerate cardiac fibrosis by activating macrophages via the integrin αVβ3/nuclear factor-κB/interleukin-6 axis.

Authors:  Naoshi Shimojo; Ryotaro Hashizume; Kazuki Kanayama; Mari Hara; Yuka Suzuki; Tomohiro Nishioka; Michiaki Hiroe; Toshimichi Yoshida; Kyoko Imanaka-Yoshida
Journal:  Hypertension       Date:  2015-08-03       Impact factor: 10.190

Review 7.  Tenascins and inflammation in disorders of the nervous system.

Authors:  Igor Jakovcevski; Djordje Miljkovic; Melitta Schachner; Pavle R Andjus
Journal:  Amino Acids       Date:  2012-12-27       Impact factor: 3.520

8.  Binding of tenascin-C to soluble fibronectin and matrix fibrils.

Authors:  C Y Chung; L Zardi; H P Erickson
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

9.  A major, six-armed glycoprotein from embryonic cartilage.

Authors:  L Vaughan; S Huber; M Chiquet; K H Winterhalter
Journal:  EMBO J       Date:  1987-02       Impact factor: 11.598

10.  Database for mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells.

Authors:  Lioudmila V Sharova; Alexei A Sharov; Timur Nedorezov; Yulan Piao; Nabeebi Shaik; Minoru S H Ko
Journal:  DNA Res       Date:  2008-11-11       Impact factor: 4.458

View more
  2 in total

1.  Tenascin-C induction exacerbates post-stroke brain damage.

Authors:  Bharath Chelluboina; Anil K Chokkalla; Suresh L Mehta; Kahlilia C Morris-Blanco; Saivenkateshkomal Bathula; Sneha Sankar; Jin Soo Park; Raghu Vemuganti
Journal:  J Cereb Blood Flow Metab       Date:  2021-10-25       Impact factor: 6.960

2.  Tenascin-C fibronectin D domain is involved in the fine-tuning of glial response to CNS injury in vitro.

Authors:  Dunja Bijelić; Marija Adžić; Mina Perić; Gebhard Reiss; Milena Milošević; Pavle R Andjus; Igor Jakovčevski
Journal:  Front Cell Dev Biol       Date:  2022-08-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.